Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulizer vs DPI for COPD Care Transitions
NCT03219866Phase 4Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2017
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: St. George's Respiratory Questionnaire at 90 days. Started Oct 2017; status: terminated.
Beyond the preview
Go deeper on NCT03219866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219866.